Elevated Serum FGG Levels Prognosticate and Promote the Disease Progression in Prostate Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevated Serum FGG Levels Prognosticate and Promote the Disease Progression in Prostate Cancer
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-29
DOI
10.3389/fgene.2021.651647
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting POH1 inhibits prostate cancer cell growth and enhances the suppressive efficacy of androgen deprivation and docetaxel
- (2019) Wandong Yu et al. PROSTATE
- Prognostic significance of pretreatment plasma fibrinogen in patients with hepatocellular and pancreatic carcinomas
- (2018) Rui Ji et al. MEDICINE
- Inhibiting Multiple Deubiquitinases to Reduce Androgen Receptor Expression in Prostate Cancer Cells
- (2018) Alicia de las Pozas et al. Scientific Reports
- Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis
- (2017) Yanlin Luo et al. Journal of Gynecologic Oncology
- An elevated preoperative plasma fibrinogen level is associated with poor overall survival in Chinese gastric cancer patients
- (2016) Weijun Yu et al. Cancer Epidemiology
- Prostate cancer
- (2016) Gerhardt Attard et al. LANCET
- Pretreatment plasma fibrinogen as an independent prognostic indicator of prostate cancer patients treated with androgen deprivation therapy
- (2016) Y Wang et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Elevated fibrinogen plasma level is not an independent predictor of poor prognosis in a large cohort of Western patients undergoing surgery for colorectal cancer
- (2016) Corrado Pedrazzani et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis
- (2015) C. Perisanidis et al. CANCER TREATMENT REVIEWS
- Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study
- (2014) Yi-Jun Shu et al. BMC CANCER
- The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients
- (2014) Eva-Maria Thurner et al. WORLD JOURNAL OF UROLOGY
- High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients
- (2013) M Pichler et al. BRITISH JOURNAL OF CANCER
- Loss of Androgen Receptor Expression Promotes a Stem-like Cell Phenotype in Prostate Cancer through STAT3 Signaling
- (2013) A. Schroeder et al. CANCER RESEARCH
- Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells
- (2013) Chengfei Liu et al. PROSTATE
- The Proinflammatory Cytokine, IL-6, and its Interference with bFGF Signaling and PSMA in Prostate Cancer Cells
- (2012) Awatef Ben Jemaa et al. INFLAMMATION
- Patients with prostate cancer treated by ADT have significantly higher fibrinogenemia than healthy control
- (2012) Stanislav Ziaran et al. WORLD JOURNAL OF UROLOGY
- Colitis-Associated Cancer Is Dependent on the Interplay between the Hemostatic and Inflammatory Systems and Supported by Integrin αMβ2Engagement of Fibrinogen
- (2010) Kris A. Steinbrecher et al. CANCER RESEARCH
- Mechanisms coupling the hemostatic system to colitis-associated cancer
- (2010) Joseph S. Palumbo et al. THROMBOSIS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started